Danaher Corporation logo
Danaher Corporation (DHR)
Compare

Danaher Corporation (DHR) EV/Assets Ratio: 1.72x

Is Danaher Corporation’s EV/Assets ratio high or low?

Danaher Corporation's EV/Assets ratio of 1.72x is 24% below its 5-year average of 2.26x, near the low end of its 5-year range (1.53x–2.95x).

The EV/Assets ratio for Danaher Corporation (DHR) is 1.72x as of Wednesday, June 10, 2026. It is below its 12-month average by 13.17% (1.98x).

DHR EV/Assets Ratio Chart

DHR EV/Assets Ratio
1.72x-15.69% 1Y
Zoom

DHR Average EV/Assets Ratio Chart

DHR Current vs Average EV/Assets Ratio Chart

DHR EV/Assets Ratio Metrics

EV/ASSETS RATIO

1.72x

EV/ASSETS RATIO AVG TTM

1.98x

EV/ASSETS RATIO AVG 3Y

2.16x

EV/ASSETS RATIO AVG 5Y

2.26x

EV/ASSETS RATIO AVG 10Y

1.96x

EV/ASSETS RATIO AVG 15Y

1.66x

EV/ASSETS RATIO AVG 20Y

1.53x

CURRENT VS TTM AVG

-13.17%

CURRENT VS 3Y AVG

-20.48%

CURRENT VS 5Y AVG

-23.83%

CURRENT VS 10Y AVG

-12.34%

CURRENT VS 15Y AVG

+3.89%

CURRENT VS 20Y AVG

+12.57%

DHR Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
Danaher Corporation (DHR)1.72x1.98x2.16x2.26x
CVS Health Corporation (CVS)$125.16B0.77x0.67x0.63x0.70x
Bristol-Myers Squibb Company (BMY)$114.14B1.72x1.55x1.56x1.64x
Pfizer Inc. (PFE)$146.36B1.01x1.00x1.03x1.28x
Intuitive Surgical, Inc. (ISRG)$146.44B7.30x8.88x9.09x8.50x
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B4.10x4.45x4.69x4.46x
Gilead Sciences, Inc. (GILD)$151.21B2.97x3.05x2.44x2.15x
Abbott Laboratories (ABT)$154.66B1.65x2.50x2.67x2.75x
Medtronic plc (MDT)$103.04B1.42x1.59x1.53x1.60x
Elevance Health Inc. (ELV)$87.43B0.88x0.80x1.03x1.13x

Danaher Corporation EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Danaher Corporation EV/Assets Ratio FAQ

What is the EV/Assets ratio for Danaher Corporation (DHR)?
The EV/Assets ratio for DHR stock is 1.72x.
Is Danaher Corporation's EV/Assets ratio high or low?
Danaher Corporation's EV/Assets ratio of 1.72x is 24% below its 5-year average of 2.26x, near the low end of its 5-year range (1.53x–2.95x).
What is the TTM average EV/Assets ratio for Danaher Corporation (DHR)?
The TTM average EV/Assets ratio for DHR stock is 1.98x.
What is the 3Y average EV/Assets ratio for Danaher Corporation (DHR)?
The 3Y average EV/Assets ratio for DHR stock is 2.16x.
What is the 5Y average EV/Assets ratio for Danaher Corporation (DHR)?
The 5Y average EV/Assets ratio for DHR stock is 2.26x.
What is the 10Y average EV/Assets ratio for Danaher Corporation (DHR)?
The 10Y average EV/Assets ratio for DHR stock is 1.96x.
What is the 15Y average EV/Assets ratio for Danaher Corporation (DHR)?
The 15Y average EV/Assets ratio for DHR stock is 1.66x.
What is the 20Y average EV/Assets ratio for Danaher Corporation (DHR)?
The 20Y average EV/Assets ratio for DHR stock is 1.53x.

Danaher Corporation EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-101.72x
2026-06-091.76x
2026-06-081.72x
2026-06-051.72x
2026-06-041.74x
2026-06-031.67x
2026-06-021.65x
2026-06-011.68x
2026-05-291.71x
2026-05-281.69x
2026-05-271.63x
2026-05-261.62x
2026-05-221.62x
2026-05-211.63x
2026-05-201.61x
2026-05-191.58x
2026-05-181.55x
2026-05-151.53x
2026-05-141.55x
2026-05-131.57x
2026-05-121.57x
2026-05-111.57x
2026-05-081.61x
2026-05-071.65x
2026-05-061.64x
2026-05-051.64x
2026-05-041.63x
2026-05-011.64x
2026-04-301.68x
2026-04-291.68x
2026-04-281.68x
2026-04-271.69x
2026-04-241.66x
2026-04-231.67x
2026-04-221.72x
2026-04-211.81x
2026-04-201.82x
2026-04-171.82x
2026-04-161.82x
2026-04-151.85x
2026-04-141.86x
2026-04-131.83x
2026-04-101.78x
2026-04-091.81x
2026-04-081.84x
2026-04-071.79x
2026-04-061.80x
2026-04-021.79x
2026-04-011.79x
2026-03-311.78x
2026-03-301.73x
2026-03-271.71x
2026-03-261.77x
2026-03-251.76x
2026-03-241.78x
2026-03-231.78x
2026-03-201.78x
2026-03-191.78x
2026-03-181.80x
2026-03-171.83x
2026-03-161.80x
2026-03-131.76x
2026-03-121.75x
2026-03-111.83x
2026-03-101.83x
2026-03-091.86x
2026-03-061.83x
2026-03-051.89x
2026-03-041.91x
2026-03-031.90x
2026-03-021.92x
2026-02-271.96x
2026-02-261.95x
2026-02-251.95x
2026-02-241.95x
2026-02-232.08x
2026-02-202.06x
2026-02-192.08x
2026-02-182.05x
2026-02-172.04x
2026-02-132.09x
2026-02-122.11x
2026-02-112.16x
2026-02-102.15x
2026-02-092.13x
2026-02-062.13x
2026-02-052.12x
2026-02-042.15x
2026-02-032.13x
2026-02-022.19x
2026-01-302.15x
2026-01-292.15x
2026-01-282.20x
2026-01-272.30x
2026-01-262.31x
2026-01-232.29x
2026-01-222.34x
2026-01-212.35x
2026-01-202.29x
2026-01-162.30x
2026-01-152.33x
2026-01-142.32x
2026-01-132.30x
2026-01-122.33x
2026-01-092.32x
2026-01-082.29x
2026-01-072.30x
2026-01-062.31x
2026-01-052.29x
2026-01-022.25x
2025-12-312.24x
2025-12-302.25x
2025-12-292.25x
2025-12-262.25x
2025-12-242.26x
2025-12-232.25x
2025-12-222.23x
2025-12-192.20x
2025-12-182.20x
2025-12-172.18x
2025-12-162.20x
2025-12-152.23x
2025-12-122.21x
2025-12-112.27x
2025-12-102.25x
2025-12-092.19x
2025-12-082.20x
2025-12-052.21x
2025-12-042.22x
2025-12-032.23x
2025-12-022.22x
2025-12-012.19x
2025-11-282.22x
2025-11-262.23x
2025-11-252.25x
2025-11-242.22x
2025-11-212.22x
2025-11-202.18x
2025-11-192.18x
2025-11-182.21x
2025-11-172.16x
2025-11-142.17x
2025-11-132.17x
2025-11-122.15x
2025-11-112.12x
2025-11-102.08x
2025-11-072.07x
2025-11-062.07x
2025-11-052.09x
2025-11-042.10x
2025-11-032.10x
2025-10-312.12x
2025-10-302.11x
2025-10-292.10x
2025-10-282.13x
2025-10-272.17x
2025-10-242.18x
2025-10-232.18x
2025-10-222.14x
2025-10-212.16x
2025-10-202.05x
2025-10-172.03x
2025-10-162.05x
2025-10-152.01x
2025-10-142.01x
2025-10-132.00x
2025-10-101.97x
2025-10-091.99x
2025-10-082.00x
2025-10-072.03x
2025-10-062.06x
2025-10-032.09x
2025-10-022.04x
2025-10-012.07x
2025-09-301.94x
2025-09-291.83x
2025-09-261.82x
2025-09-251.79x
2025-09-241.83x
2025-09-231.86x
2025-09-221.87x
2025-09-191.89x
2025-09-181.91x
2025-09-171.89x
2025-09-161.87x
2025-09-151.85x
2025-09-121.87x
2025-09-111.91x
2025-09-101.89x
2025-09-091.90x
2025-09-081.94x
2025-09-051.96x
2025-09-041.94x
2025-09-031.95x
2025-09-021.99x
2025-08-292.00x
2025-08-282.00x
2025-08-272.00x
2025-08-262.01x
2025-08-252.02x
2025-08-222.06x
2025-08-211.99x
2025-08-202.05x
2025-08-192.06x
2025-08-182.03x
2025-08-152.05x
2025-08-142.04x
2025-08-132.03x
2025-08-122.00x
2025-08-111.95x
2025-08-081.96x
2025-08-071.94x
2025-08-061.91x
2025-08-051.94x
2025-08-041.93x
2025-08-011.93x
2025-07-311.93x
2025-07-301.99x
2025-07-292.01x
2025-07-281.98x
2025-07-252.00x
2025-07-241.98x
2025-07-231.93x
2025-07-221.86x
2025-07-211.85x
2025-07-181.93x
2025-07-171.97x
2025-07-161.96x
2025-07-151.95x
2025-07-142.00x
2025-07-112.06x
2025-07-102.07x
2025-07-092.03x
2025-07-082.03x
2025-07-072.02x
2025-07-032.05x
2025-07-022.04x
2025-07-012.03x
2025-06-302.00x
2025-06-272.01x
2025-06-262.03x
2025-06-252.03x
2025-06-242.00x
2025-06-231.99x
2025-06-201.99x
2025-06-181.97x
2025-06-171.98x
2025-06-162.03x
2025-06-132.03x
2025-06-122.07x
2025-06-112.06x
2025-06-102.04x
2025-06-092.01x
2025-06-061.98x
2025-06-051.95x
2025-06-041.96x
2025-06-031.95x
2025-06-021.92x
2025-05-301.93x
2025-05-291.93x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair